chlorambucil has been researched along with Graft-Versus-Host Disease in 3 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jurkovicova, J | 1 |
| Xicoy, B | 1 |
| Bielsa, I | 1 |
| Arellano, A | 1 |
| Kodo, H | 1 |
| Lemmel, EM | 1 |
| Motycka, K | 1 |
| Soucek, J | 1 |
| Nouza, K | 1 |
1 review available for chlorambucil and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Graft-versus-host disease.
Topics: Bone Marrow Transplantation; Cardiac Surgical Procedures; Chlorambucil; Cytomegalovirus Infections; | 1987 |
2 other studies available for chlorambucil and Graft-Versus-Host Disease
| Article | Year |
|---|---|
[Sustained molecular remission in an adult patient with Sézary syndrome after peripheral allogeneic stem-cell transplantation].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy; Fema | 2011 |
[The influence of age and experimentally-induced disease on the tolerance of cytostatically-active materials in mice].
Topics: Age Factors; Aminopterin; Animals; Antineoplastic Agents; Busulfan; Chlorambucil; Cyclophosphamide; | 1967 |